SCHEMBL3165247

SCHEMBL3165247

CC(=O)NCCNc1cc(NC(=O)CN2CCC(O)(c3ccc(Cl)c(C(F)(F)F)c3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 11/20 0.49
▸ OPRL1 P41146 8/20 0.49
▸ SCN1A P35498 1/20 0.48
▸ SCN2A Q99250 1/20 0.48
▸ SCN3A Q9NY46 1/20 0.48
▸ OPRD1 P41143 5/20 0.44
▸ OPRK1 P41145 4/20 0.44
▸ HTR1A P08908 3/20 0.44
▸ DRD2 P14416 3/20 0.44
▸ DRD1 P21728 3/20 0.44
▸ DRD4 P21917 3/20 0.44
▸ DRD5 P21918 3/20 0.44
▸ SLC6A2 P23975 3/20 0.44
▸ HRH2 P25021 3/20 0.44
▸ HTR1D P28221 3/20 0.44
▸ HTR2A P28223 3/20 0.44
▸ HTR2C P28335 3/20 0.44
▸ SLC6A4 P31645 3/20 0.44
▸ HTR7 P34969 3/20 0.44
▸ DRD3 P35462 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3163863 0.88 POLB (0.45) OPRM1OPRL1SCN1ASCN2ASCN3A
SCHEMBL3172100 0.87 OPRL1 (0.49) OPRM1OPRL1OPRD1OPRK1DRD4
SCHEMBL3165134 0.87 ALDH1A1 (0.48) ALDH1A1LMNAMAPK1HTTSMN1; SMN2
SCHEMBL3169426 0.85 POLB (0.45) DRD2DRD4DRD3ALDH1A1LMNA
SCHEMBL3170318 0.80 LMNA (0.42) OPRD1ALDH1A1MAPTLMNACYP1A2
SCHEMBL3161434 0.80 ADORA1 (0.42) ALDH1A1LMNAMAPK1HTTSMN1; SMN2
SCHEMBL3162879 0.79 UTS2R (0.44) DRD2SLC6A2HTR2AHTR2CSLC6A4
SCHEMBL3163125 0.78 NPC1 (0.47) ALDH1A1MAPTNPSR1
SCHEMBL3164709 0.78 NPC1 (0.47) ALDH1A1MAPTNPSR1
SCHEMBL3156278 0.78 ALDH1A1 (0.44) ALDH1A1MAPTLMNACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback